2023-02-24T15:17:11-06:00 2022-06-30 420714325 RSM US LLP 100 INTERNATIONAL DRIVE SUITE 1400 BALTIMORE MD 21202 990 2021-07-01 263670453 QLARANT INC QLAR 8668862658 28464 MARLBORO AVENUE EASTON MD 21601 DANA FIDLER CHIEF FINANCIAL OFFICER 8668862658 2023-02-23 1 DANA FIDLER 999009999 JULIA FLANNERY P00928918 4102469300 2023-02-23 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z RONALD FORSYTHE 28464 MARLBORO AVENUE EASTON MD 21601 1969708 0 X WWW.QLARANT.COM X 2007 MD PROVIDES GOVERNMENT CONTRACTING, AUDITING, MONITORING & CONSULTING FOR THE HEALTH CARE INDUSTRY. 10 4 102 0 0 0 1760795 1950538 0 0 0 6628 92259 12542 1853054 1969708 0 0 0 0 10811305 12416405 0 0 0 -8739247 -11023152 2072058 1393253 -219004 576455 4953049 5076836 3774501 3401268 1178548 1675568 QLARANT INC'S, MISSION IS TO IMPROVE HEALTH IN THE COMMUNITIES WE SERVE. 0 0 MONITORING AND IMPROVING THE DELIVERY OF HEALTH CARE SERVICES AND INVESTIGATING HEALTH CARE FRAUD, WASTE AND ABUSE. 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 99 0 1 102 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 4 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MD CA X DANA FIDLER CHIEF FINANCIAL OFFICER 8668862658 28464 MARLBORO AVENUE EASTON MD 21601 AMANDA NEAL BOARD MEMBER 1.00 1.00 X 10000 0 0 ANTHONY KERN VICE CHAIR 1.75 3.75 X X 11500 0 0 BRIAN GRISSLER SECRETARY/TREASURER 1.00 1.00 X X 11250 0 0 CATHERINE N SMOOT-HASELNUS MD CHAIR (THRU 11/30/21) 1.50 1.50 X X 30000 0 0 HARBHAJAN AJRAWAT MD BOARD MEMBER 1.50 2.50 X 12000 0 0 HERBERT CHAIN BOARD MEMBER (BEG 11/1/21) 1.00 3.00 X 3000 8000 0 JOHN MURRAY CHAIR 1.50 1.50 X X 15000 0 0 MARGARET GALLAHER MD BOARD MEMBER (THRU 12/31/21) 1.50 1.50 X 12000 0 0 MELVIN GERALD BOARD MEMBER (THRU 11/30/21) 1.00 3.00 X 10000 6000 0 MICHAEL MOSKEWICZ MD BOARD MEMBER 1.50 1.50 X 11000 0 0 MIDGETT PARKER JR BOARD MEMBER 1.50 1.50 X 10000 0 0 REGINA KNOX-WOODS BOARD MEMBER 1.50 3.50 X 10000 0 0 S ALLAN ADELMAN BOARD MEMBER (BEG 1/1/22) 1.00 3.00 X 0 10000 0 DANA FIDLER CFO (BEG 4/21) 0.00 52.00 X 3000 209017 3544 RON FORSYTHE JR CEO 0.00 52.00 X 0 643006 70020 BRIAN CLEARY CHIEF INFOMATION OFFICER 0.00 50.00 X 0 203602 43810 DEBORAH KELLER VP, HUMAN RESOURCES 0.00 50.00 X 0 325640 41644 SHANNON WOLFE CORPORATE SECURITY OFFICER 0.00 50.00 X 0 203252 19496 DANIEL EDRIS DIRECTOR, DATA MANAGEMENT 0.00 50.00 X 0 164619 52442 HONGLI PU VP, NEW PRODUCT DEVELOPMENT 0.00 50.00 X 0 221922 52475 LAUREN DULIN DIRECTOR, HUMAN RESOURCES 0.00 50.00 X 0 149394 40612 WILLIAM MAPP CHIEF TECHNOLOGY OFFICER 0.00 50.00 X 0 221728 53199 ZEHRA ZAIDI DIRECTOR, PRODUCT DEV (THRU 12/10/21) 0.00 50.00 X 0 177741 16029 148750 2543921 393271 28 0 1 0 MCCARTER & ENGLISH LLP FOUR GATEWAY CENTER NEWARK NJ 07102 LEGAL COUNSEL 545169 INBAND NETWORKS LLC 6030 MARSHALEE DR STE 703 ELKRIDGE MD 21075 IT LICENSES/SUPPORT (CISCO) 353939 VIVID PAGES INC 9701 APOLLO DRIVE SUITE 301 LARGO MD 20774 TECHNOLOGY DEVELOPMENT 280842 RSM US LLP 5155 PAYSPHERE CIRCLE CHICAGO IL 60674 AUDIT/CONSULTING/TAX 237935 TECHNOLOGY RIVERS 23416 SUMMERSTOWN PL STERLING VA 20166 SOFTWARE PROGRAMMING/DEVELOPMENT 178657 7 1950538 1950538 6628 0 6628 6628 6628 OTHER INCOME 900099 12542 12542 12542 1969708 0 0 19170 145000 145000 9723398 9723398 806699 806699 1094630 1094630 646678 646678 402009 402009 29390 29390 2 2 611 611 3552 3552 IMPAIRMENT 589258 589258 ALLOCATION TO SUBSIDIAR -12047974 -12047974 1393253 0 1393253 0 943959 575999 1305805 1451194 4574409 2975530 2179156 1598879 473900 50229 1450764 4953049 5076836 3088147 2630732 686354 770536 3774501 3401268 X 1178548 1675568 1178548 1675568 4953049 5076836 X 576455 -79435 X 0 1 X 1 0 X X X 4 QLARANT QUALITY SOLUTIONS INC 521000082 7 1 0 0 QLARANT ADVISORY SOLUTIONS INC 522334320 7 1 0 0 QLARANT FOUNDATION INC 200065799 7 1 0 0 QLARANT INTEGRITY SOLUTIONS LLC 203796994 10 1 0 0 4 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 0 0 0 0 0 1393253 84897507 1393253 84897507 214325 1000000 53581 250000 0 0 0 0 1000000 1000000 1000000 1000000 4000000 6000000 90677 3103 93780 250000 250000 250000 250000 1000000 1500000 959252 507142 452110 3296514 2468388 828126 318643 318643 1598879 DEPOSITS 55471 INVESTMENT IN SUBSIDIARY 300000 DUE FROM RELATED PARTY 1095293 1450764 PROVISION FOR INSURANCE CLAIMS 167248 DEFERRED RENT 603288 770536 X 82092890 80123182 80123182 1969708 0 1969708 82782854 81389601 81389601 1393253 0 1393253 PART X, LINE 2: THE COMPANY FOLLOWS THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, THE COMPANY MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION CLASSIFICATION, INTEREST, PENALTIES ON INCOME TAXES AND ACCOUNTING IN INTERIM PERIODS. MANAGEMENT HAS EVALUATED THE COMPANY'S TAX POSITIONS AND HAS CONCLUDED THAT THE COMPANY HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISION OF THIS GUIDANCE. PART XI, LINE 2D - OTHER ADJUSTMENTS: REVENUE FROM AFFILIATES INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 80,123,182. PART XII, LINE 2D - OTHER ADJUSTMENTS: EXPENSES FROM AFFILIATES INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 81,389,601. X X X X X 0 0 0 0 0 0 0 1 0 RON FORSYTHE JR CEO 0 488794 0 153450 0 762 0 31313 0 38707 0 713026 0 0 DEBORAH KELLER VP, HUMAN RESOURCES 0 263930 0 59764 0 1946 0 26634 0 15010 0 367284 0 0 WILLIAM MAPP CHIEF TECHNOLOGY OFFICER 0 164834 0 56731 0 163 0 17140 0 36059 0 274927 0 0 HONGLI PU VP, NEW PRODUCT DEVELOPMENT 0 178592 0 43050 0 280 0 18566 0 33909 0 274397 0 0 BRIAN CLEARY CHIEF INFOMATION OFFICER 0 165322 0 37954 0 326 0 17063 0 26747 0 247412 0 0 SHANNON WOLFE CORPORATE SECURITY OFFICER 0 172550 0 30372 0 330 0 17295 0 2201 0 222748 0 0 DANIEL EDRIS DIRECTOR, DATA MANAGEMENT 0 144451 0 19776 0 392 0 15441 0 37001 0 217061 0 0 DANA FIDLER CFO (BEG 4/21) 3000 183369 0 25396 0 252 0 0 0 3544 3000 212561 0 0 ZEHRA ZAIDI DIRECTOR, PRODUCT DEV (THRU 12/10/21 0 157722 0 19902 0 117 0 14933 0 1096 0 193770 0 0 LAUREN DULIN DIRECTOR, HUMAN RESOURCES 0 131195 0 17703 0 496 0 13907 0 26705 0 190006 0 0 PART I, LINE 7 THE ORGANIZATION PAID DISCRETIONARY BONUSES IN 2021. FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE AMENDED TO BECOME COMPATIBLE WITH MARYLAND GUIDELINES. CHANGES WERE MADE AS FOLLOWS: - CHAPTER II CORPORATE POWERS: SECTION I - CORPORATE POWERS VESTED IN BOARD OF DIRECTORS IS AMENDED TO ESTABLISH A MINIMUM (3) AND MAXIMUM (15) NUMBER OF DIRECTORS. - CHAPTER III BOARD OF DIRECTORS: SECTION I - TERMS OF OFFICE IS AMENDED TO ESTABLISH TERM LIMITS FOR DIRECTORS. - CHAPTER V OFFICERS: SECTION III - ELECTION IS AMENDED TO ESTABLISH TERM LIMITS FOR THE CHAIRMAN OF THE BOARD. - CHAPTER VII EXECUTIVE COMMITTEE AND OTHER COMMITTEES ESTABLISHED BY DIRECTORS: SECTIONS I AND II ARE AMENDED TO STATE THAT COMMITTEE MEMBERS SHALL BE NOMINATED BY THE CHAIRMAN AND APPOINTED/CONFIRMED BY THE DIRECTORS FROM AMONG THE BOARD'S MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE CEO, CFO, AND THE FINANCE COMMITTEE. THE BOARD OF DIRECTORS RECEIVES A COPY OF THE RETURN PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS PARTICIPATES IN ANNUAL COMPLIANCE TRAINING AND CONFLICT OF INTEREST TRAINING GIVEN BY THE COMPLIANCE OFFICER. EACH BOARD MEMBER, THE CEO, COO, AND CFO ARE REQUIRED TO COMPLETE AND SIGN A CONFLICT OF INTEREST QUESTIONNAIRE ON AN ANNUAL BASIS. THERE MAY BE A MATTER WHERE A MEMBER, OR A MEMBER OF THE MEMBER'S FAMILY, MAY HAVE A MATERIAL PERSONAL INTEREST IN A TRANSACTION OR COURSE OF ACTION IN WHICH QLARANT, INC. IS, OR MAY BE, INVOLVED. IN SUCH CIRCUMSTANCES, THE MEMBER SHALL NOT PARTICIPATE IN THE VOTING UPON, OR DISCUSSION OF, THE MATTER EXCEPT UNDER THE FOLLOWING CIRCUMSTANCES: 1. A REQUEST TO PARTICIPATE IS MADE TO THE COMPLIANCE COMMITTEE ALONG WITH FULL DISCLOSURE OF THE POTENTIAL CONFLICT AND ALL RELEVANT FACTS; AND 2. THE COMPLIANCE COMMITTEE DETERMINES THAT A MATERIAL PERSONAL INTEREST IS NOT INVOLVED; AND 3. THE BOARD IS FULLY ADVISED OF THE COMPLIANCE COMMITTEE'S DETERMINATION. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR ALL ASSOCIATES IS MANAGED THE SAME WAY WITH EXCEPTION OF THE CEO. HR IS RESPONSIBLE FOR ENSURING THAT EACH POSITION IS GRADED PROPERLY BASED ON EXTERNAL BENCHMARK DATA. COMPENSATION FOR THE VARIOUS POSITION RANGES ARE IN COMPLIANCE WITH LOCAL REQUIREMENTS, WHERE REQUIRED, AND EXTERNALLY BENCHMARKED TO ENSURE APPROPRIATE EQUITY. ANNUALLY, THE MERIT CONTRIBUTION ASSUMPTIONS ARE APPROVED BY THE BOARD. HR THEN OVERSEES EXECUTION OF THE MERIT PLANNING PROCESS BY THE ORGANIZATION BASED ON APPROVED BOARD ASSUMPTIONS. THE CEO REVIEWS THE OVERALL PLAN WITH THE VICE PRESIDENT OF HR FOR COMPLIANCE AND APPROPRIATE DISTRIBUTION BASED ON EMPLOYEE PERFORMANCE AND ALIGNMENT WITH OVERALL COMPENSATION PAY RANGES. THIS COMMON PROCESS IS FOLLOWED FOR ALL COMPANY EMPLOYEES WITH EXCEPTION OF THE CEO. THE EXECUTIVE BOARD REVIEWS AND APPROVES COMPENSATION OF THE CEO ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART XI, LINE 9: QCS INTERCOMPANY ADJUSTMENT -79,435. QLARANT TECHNOLOGY SOLUTIONS LLC 28464 MARLBORO AVENUE EASTON MD 21601 873551418 TECHNOLOGY SOLUTION FOR HEALTH ASSESSMENT MD 0 0 QLARANT INC QLARANT FOUNDATION INC 28464 MARLBORO AVENUE EASTON MD 21601 200065799 GRANT MAKING MD 501(C)(3) LINE 7 QLARANT INC 1 QLARANT ADVISORY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 522334320 HEALTH ASSESSMENT DC 501(C)(3) LINE 7 QLARANT INC 1 QLARANT QUALITY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521000082 HEALTH ASSESSMENT MD 501(C)(3) LINE 7 QLARANT INC 1 QLARANT INTEGRITY SOLUTIONS LLC 28464 MARLBORO AVENUE EASTON MD 21601 203796994 HEALTH ASSESSMENT MD 501(C)(3) LINE 10 QLARANT INC 1 QLARANT COMMERCIAL SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521798961 PATIENT SAFETY PRODUCTS & SERVICES MD QLARANT INC C 1233 301233 1.00000 1 0 1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 0 0 QLARANT INTEGRITY SOLUTIONS LLC C 1222420 ACTUAL COST QLARANT INTEGRITY SOLUTIONS LLC O 6125950 ACTUAL COST QLARANT INTEGRITY SOLUTIONS LLC N 975194 ACTUAL COST QLARANT INTEGRITY SOLUTIONS LLC Q 8373206 ACTUAL COST QLARANT QUALITY SOLUTIONS INC O 2161209 ACTUAL COST QLARANT QUALITY SOLUTIONS INC N 138571 ACTUAL COST QLARANT QUALITY SOLUTIONS INC C 728118 ACTUAL COST QLARANT QUALITY SOLUTIONS INC Q 2462387 ACTUAL COST QLARANT FOUNDATION O 37336 ACTUAL COST QLARANT FOUNDATION N 11346 ACTUAL COST QLARANT FOUNDATION Q 20951 ACTUAL COST QLARANT COMMERCIAL SOLUTIONS INC B 300000 ACTUAL COST QLARANT QUALITY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 521000082 X 0 0 0 15620247 15620247 931012 232753 0 0 0 QLARANT INC 28464 MARLBORO AVENUE EASTON MD 21601 263670453 0 0 0 1393253 1393253 214325 53581 0 0 0 QLARANT ADVISORY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 522334320 X 0 0 0 164115 164115 32823 8206 0 0 0 QLARANT FOUNDATION INC 28464 MARLBORO AVENUE EASTON MD 21601 200065799 X 0 0 0 556546 556546 108482 27121 0 0 0 QLARANT INTEGRITY SOLUTIONS INC 28464 MARLBORO AVENUE EASTON MD 21601 203796994 0 0 0 67163346 67163346 1000000 250000 0 0 0